首页> 美国卫生研究院文献>Annals of Translational Medicine >Digital chest tomosynthesis: the 2017 updated review of an emerging application
【2h】

Digital chest tomosynthesis: the 2017 updated review of an emerging application

机译:数字化胸部断层合成:2017年更新的新兴应用综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer is the leading cause of cancer death and second most common cancer among both men and women, but most of them are detected when patients become symptomatic and in late-stage. Chest radiography (CR) is a basic technique for the investigation of lung cancer and has the benefit of convenience and low radiation dose, but detection of malignancy is often difficult. The introduction of computed tomography (CT) for screening has increased the proportion of lung cancer detected but with higher exposure dose and higher costs. Digital chest tomosynthesis (DCT), a tomographic technique, may offer an alternative to CT. DCT uses a conventional radiograph tube, a flat-panel detector, a computer-controlled tube mover and reconstruction algorithms to produce section images. It shows promise in the detection of potentially malignant lung nodules, with higher sensibility than CR, and is emerging as a low-dose and low-cost alternative to CT to improve treatment decisions. In fact, an increasing number of researchers are showing that tomosynthesis could have a role in the detection of lung cancer, in addition to its present role in breast screening. However, DCT offers some limitations, such as limited depth resolution, which may explain the difficulty in detecting pathologies in the subpleural region and the occurrence of artefacts from medical devices. Once solved these limitations and once more studies supporting its use will be available, DCT could become the first-line lung cancer screening tool among patients at considerable risk of lung cancer.
机译:肺癌是导致癌症死亡的主要原因,也是男性和女性中第二常见的癌症,但大多数在患者出现症状和处于晚期时才被发现。胸部放射线照相术(CR)是研究肺癌的一项基本技术,具有便利性和低放射剂量的优势,但通常很难检测到恶性肿瘤。引入计算机断层扫描(CT)进行筛查已增加了检测到的肺癌比例,但暴露剂量更高且成本更高。数字化胸部断层合成(DCT)是一种断层扫描技术,可以提供CT的替代方法。 DCT使用常规的射线照相管,平板探测器,计算机控制的管子移动器和重建算法来生成断层图像。它在检测潜在的恶性肺结节方面显示出希望,其敏感性比CR高,并且正在成为CT的低剂量,低成本替代方案,以改善治疗决策。实际上,越来越多的研究人员表明,断层合成除了目前在乳腺癌筛查中的作用外,还可能在检测肺癌中发挥作用。但是,DCT提供了一些限制,例如有限的深度分辨率,这可能解释了在胸膜下区域检测病状的困难以及医疗器械出现伪像的困难。一旦解决了这些局限性,一旦有更多的研究支持其使用,DCT可能会成为罹患肺癌的高风险患者中的一线肺癌筛查工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号